SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-24-011100
Filing Date
2024-08-27
Accepted
2024-08-26 18:04:18
Documents
5
Period of Report
2024-08-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K fsd_6k.htm 6-K 17724
2 AR FSD PHARMA LICENSING AGREEMENT fsd_ex41.htm EX-4.1 392002
3 INTELLECTUAL PROPERTY ASSIGNMENT AGREEMENT fsd_ex42.htm EX-4.2 21115
4 AMENDED AND RESTATED LOAN AGREEMENT fsd_ex43.htm EX-4.3 29827
5 AMENDED AND RESTATED GENERAL SECURITY AGREEMENT fsd_ex44.htm EX-4.4 162422
  Complete submission text file 0001654954-24-011100.txt   624299
Mailing Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4
Business Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4 (416) 854-8884
Quantum Biopharma Ltd. (Filer) CIK: 0001771885 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39152 | Film No.: 241242725
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)